Corus raises $60 million

Corus Pharma (Seattle, Wash.) raised $60 million in a series C round led by Bear Stearns. Other investors included Hambrecht & Quist; AIG Sun America Ventures; MPM BioEquities; the Carnegie Group; JP Morgan; Novo A/S; RBC Capital; Burrill; OrbiMed; MDS Capital; Cascade Investment; Anthem Ventures; Pacific Rim Ventures; Washington Research Foundation; Integra Ventures; WestRiver Capital; and Kirby Cramer, Corus' chairman. Montgomery & Co. was the placement agent. ...